IL164564A0 - Combination therapy for the treatment of cancer - Google Patents
Combination therapy for the treatment of cancerInfo
- Publication number
- IL164564A0 IL164564A0 IL16456404A IL16456404A IL164564A0 IL 164564 A0 IL164564 A0 IL 164564A0 IL 16456404 A IL16456404 A IL 16456404A IL 16456404 A IL16456404 A IL 16456404A IL 164564 A0 IL164564 A0 IL 164564A0
- Authority
- IL
- Israel
- Prior art keywords
- cancer
- treatment
- effective amount
- combination therapy
- warm
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0208680A GB0208680D0 (en) | 2002-04-16 | 2002-04-16 | Combination therapy |
GB0218388A GB0218388D0 (en) | 2002-08-08 | 2002-08-08 | Combination therapy |
PCT/GB2003/001617 WO2003088971A1 (en) | 2002-04-16 | 2003-04-14 | Combination therapy for the treatment of cancer |
Publications (1)
Publication Number | Publication Date |
---|---|
IL164564A0 true IL164564A0 (en) | 2005-12-18 |
Family
ID=29252451
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL16456404A IL164564A0 (en) | 2002-04-16 | 2004-10-13 | Combination therapy for the treatment of cancer |
Country Status (17)
Country | Link |
---|---|
US (1) | US20050215530A1 (de) |
EP (1) | EP1496909B1 (de) |
JP (1) | JP2005530735A (de) |
KR (1) | KR20040103964A (de) |
CN (1) | CN100352441C (de) |
AT (1) | ATE353650T1 (de) |
AU (1) | AU2003216558B2 (de) |
BR (1) | BR0309226A (de) |
CA (1) | CA2482591A1 (de) |
DE (1) | DE60311788T2 (de) |
ES (1) | ES2280735T3 (de) |
HK (1) | HK1071310A1 (de) |
IL (1) | IL164564A0 (de) |
MX (1) | MXPA04010166A (de) |
NO (1) | NO20044498L (de) |
NZ (1) | NZ535739A (de) |
WO (1) | WO2003088971A1 (de) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0218526D0 (en) * | 2002-08-09 | 2002-09-18 | Astrazeneca Ab | Combination therapy |
KR20060036058A (ko) * | 2003-06-18 | 2006-04-27 | 앤지오젠 파마슈티칼스 리미티드 | 결장직장암의 치료를 위한 혈관 손상 활성을 갖는 5fu,cpt-11 또는 5-fu 및 cpt-11과 함께 zd6126을포함하는 조성물 |
CN1898240B (zh) * | 2003-10-15 | 2011-08-03 | Osi制药公司 | 咪唑并吡嗪类酪氨酸激酶抑制剂 |
BRPI0509576A (pt) * | 2004-04-02 | 2007-05-29 | Osi Pharm Inc | composto, método de tratamento de um paciente tendo uma condição que é mediada pela atividade de proteìna quinase, e, composição farmacêutica |
CN1968706A (zh) | 2004-06-03 | 2007-05-23 | 霍夫曼-拉罗奇有限公司 | 用顺铂和egfr-抑制剂治疗 |
AU2005251722B2 (en) * | 2004-06-03 | 2009-11-12 | Smithkline Beecham (Cork) Limited | Cancer treatment method |
US20060084666A1 (en) * | 2004-10-18 | 2006-04-20 | Harari Paul M | Combined treatment with radiation and an epidermal growth factor receptor kinase inhibitor |
FR2886151B1 (fr) * | 2005-05-31 | 2007-09-07 | Mayoly Spindler Soc Par Action | Utilisation de la colchicine pour la preparation d'un medicament destine a la prevention et/ou au traitement de l'endometriose |
US8575164B2 (en) * | 2005-12-19 | 2013-11-05 | OSI Pharmaceuticals, LLC | Combination cancer therapy |
WO2009091939A1 (en) * | 2008-01-18 | 2009-07-23 | Osi Pharmaceuticals, Inc. | Imidazopyrazinol derivatives for the treatment of cancers |
JP2011520970A (ja) * | 2008-05-19 | 2011-07-21 | オーエスアイ・フアーマスーテイカルズ・インコーポレーテツド | 置換されたイミダゾピラジン類およびイミダゾトリアジン類 |
EP2408479A1 (de) | 2009-03-18 | 2012-01-25 | OSI Pharmaceuticals, LLC | Kombinationskrebstherapie mit verabreichung eines egfr-hemmers und eines igf-1r-hemmers |
CA2752826A1 (en) | 2009-04-20 | 2010-10-28 | OSI Pharmaceuticals, LLC | Preparation of c-pyrazine-methylamines |
JP2012526138A (ja) * | 2009-05-07 | 2012-10-25 | オーエスアイ・ファーマシューティカルズ,エルエルシー | 副腎皮質癌を治療するためのosi−906の使用 |
WO2012129145A1 (en) | 2011-03-18 | 2012-09-27 | OSI Pharmaceuticals, LLC | Nscle combination therapy |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9300059D0 (en) * | 1992-01-20 | 1993-03-03 | Zeneca Ltd | Quinazoline derivatives |
GB9508538D0 (en) * | 1995-04-27 | 1995-06-14 | Zeneca Ltd | Quinazoline derivatives |
GB9714249D0 (en) * | 1997-07-08 | 1997-09-10 | Angiogene Pharm Ltd | Vascular damaging agents |
EE200200565A (et) * | 2000-03-31 | 2004-06-15 | Angiogene Pharmaceuticals Ltd. | Vaskulaarse kahjustava toimega kombinatsioonravi |
GB0008269D0 (en) * | 2000-04-05 | 2000-05-24 | Astrazeneca Ab | Combination chemotherapy |
-
2003
- 2003-04-14 CN CNB03813702XA patent/CN100352441C/zh not_active Expired - Fee Related
- 2003-04-14 MX MXPA04010166A patent/MXPA04010166A/es active IP Right Grant
- 2003-04-14 EP EP03712464A patent/EP1496909B1/de not_active Expired - Lifetime
- 2003-04-14 DE DE60311788T patent/DE60311788T2/de not_active Expired - Fee Related
- 2003-04-14 CA CA002482591A patent/CA2482591A1/en not_active Abandoned
- 2003-04-14 AU AU2003216558A patent/AU2003216558B2/en not_active Ceased
- 2003-04-14 JP JP2003585723A patent/JP2005530735A/ja active Pending
- 2003-04-14 AT AT03712464T patent/ATE353650T1/de not_active IP Right Cessation
- 2003-04-14 US US10/511,744 patent/US20050215530A1/en not_active Abandoned
- 2003-04-14 ES ES03712464T patent/ES2280735T3/es not_active Expired - Lifetime
- 2003-04-14 NZ NZ535739A patent/NZ535739A/en unknown
- 2003-04-14 BR BR0309226-7A patent/BR0309226A/pt not_active IP Right Cessation
- 2003-04-14 KR KR10-2004-7016666A patent/KR20040103964A/ko not_active Application Discontinuation
- 2003-04-14 WO PCT/GB2003/001617 patent/WO2003088971A1/en active IP Right Grant
-
2004
- 2004-10-13 IL IL16456404A patent/IL164564A0/xx unknown
- 2004-10-21 NO NO20044498A patent/NO20044498L/no not_active Application Discontinuation
-
2005
- 2005-05-23 HK HK05104297A patent/HK1071310A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
EP1496909A1 (de) | 2005-01-19 |
DE60311788D1 (de) | 2007-03-29 |
DE60311788T2 (de) | 2007-11-22 |
CN100352441C (zh) | 2007-12-05 |
AU2003216558B2 (en) | 2008-05-29 |
US20050215530A1 (en) | 2005-09-29 |
ATE353650T1 (de) | 2007-03-15 |
BR0309226A (pt) | 2005-02-09 |
EP1496909B1 (de) | 2007-02-14 |
NO20044498L (no) | 2004-11-04 |
KR20040103964A (ko) | 2004-12-09 |
CA2482591A1 (en) | 2003-10-30 |
HK1071310A1 (en) | 2005-07-15 |
WO2003088971A1 (en) | 2003-10-30 |
CN1658880A (zh) | 2005-08-24 |
AU2003216558A1 (en) | 2003-11-03 |
JP2005530735A (ja) | 2005-10-13 |
MXPA04010166A (es) | 2005-02-03 |
ES2280735T3 (es) | 2007-09-16 |
NZ535739A (en) | 2008-01-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1071310A1 (en) | Combination therapy for the treatment of cancer | |
HK1078771A1 (en) | Use of the quinazoline derivative zd6474 combined with gemcitabine and optionally ionising radiationin the treatment of cancer | |
MX2007003505A (es) | Combinacion que comprende zd6474 e imatinib. | |
NO20071426L (no) | Kreft kombinasjonsbehandling omfattende AZD2171 og Imatinib | |
IS6558A (is) | Blandaðar sjúkdómsmeðferðir með æðaskaðandi virkni | |
HRP20080597T3 (en) | Cancer combination therapy comprising azd2171 and zd1839 | |
HK1123976A1 (en) | Combination of azd2171 and pemetrexed azd2171 | |
HK1096023A1 (en) | Combination therapy with azd2171 and 5-fu and/or cpt-11 azd2171?5-fu?cpt-11 | |
MXPA05008583A (es) | Terapia de combinacion de zd6474 con 5-fu y/o cpt-11. | |
ZA200600188B (en) | Combination therapy | |
NO20064753L (no) | Kombinasjonsterapi | |
WO2007003933A3 (en) | Combination therapy of cancer with azd2171 and gemcitabine | |
BRPI0508983A (pt) | uso de azd2171 ou de um sal deste farmaceuticamente aceitável excluido um sal de maleato de azd2171 e um taxano, composição farmacêutica, kit, e, método para a produção de efeito antiangiogênico e/ou de redução da permeabilidade vascular em um animal de sangue quente tal como um ser humano | |
GB0223379D0 (en) | Combination therapy |